Novartis moves away from mass-market drugs

Janet Babin Sep 25, 2018
Share Now on:
HTML EMBED:
COPY

Novartis moves away from mass-market drugs

Janet Babin Sep 25, 2018
Share Now on:
HTML EMBED:
COPY

Drugmaker Novartis announced it’s cutting more than 2,000 jobs — most of them in Europe — as part of a global restructuring. The company plans to focus on producing and selling more innovative drugs, but these specified medicines require lots of research and carry higher price tags.

Click the audio player above to hear the full story.

As a nonprofit news organization, our future depends on listeners like you who believe in the power of public service journalism.

Your investment in Marketplace helps us remain paywall-free and ensures everyone has access to trustworthy, unbiased news and information, regardless of their ability to pay.

Donate today — in any amount — to become a Marketplace Investor. Now more than ever, your commitment makes a difference.